AICDA

Immune System · B-Cell Receptor Signaling & Antibody Repertoire

How do immune cells improve and change the antibodies they make?

AICDA helps B cells alter antibody genes through processes including class switching and somatic hypermutation. These changes let antibody responses become better suited to different immune challenges.

Common Gene Name
activation induced cytidine deaminase
NCBI Gene ID
57379
Chromosome
12

Clinical Evidence Status

Established disease relationship

These labels describe available evidence about a gene. They do not classify your variant or recommend a treatment.

Answer Sources

Explore supporting evidence (2 records)
Condition or drugEvidenceGrade / statusContextSource
hyper-IgM syndrome type 2ClinGen gene-disease validityDefinitiveAutosomal recessiveView source
2024-08-28
hyper-IgM syndrome type 2ClinGen gene-disease validityDefinitiveAutosomal dominantView source
2024-08-28

Source snapshot: 2026-09-09. Consumer text updated: 2026-09-10. Source dates describe the cited records, not a new clinical review.

← Back to Immune System